|Articles|June 1, 2019
- Applied Clinical Trials-06-01-2019
- Volume 28
- Issue 6
Applied Clinical Trials, June 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 7 years ago
Master Protocol Guidance in Cancer R&D: Impact on Industryabout 7 years ago
The Benefits of RWD & RWE in Oncology Trialsabout 7 years ago
Glimpsing the Future of Clinical Trial Designabout 7 years ago
FDA Facilitates Expanded Access for Cancer Drugsabout 7 years ago
Real-World Evidence Gains Traction for Informing Clinical Researchabout 7 years ago
News Notesabout 7 years ago
Navigating Drug Development Through More Turbulent Watersabout 7 years ago
Building a Physician Referral Network: A Case Studyabout 7 years ago
Predicting the Probability of Success in Clinical Drug Developmentabout 7 years ago
Reveling in 2018's Revealing Drug and Biologic ApprovalsAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The CRA of the Future: From Monitoring Activity to Strategic Site Partnership
2
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
3
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
4
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
5